Could interleukin-1 antagonists be the answer to managing acute gout? Guidelines for the management of this disorder, issued by the European League Against Rheumatism (EULAR) and the British ...
Hangzhou Polymed Biopharmaceuticals Inc. has synthesized crystalline forms of compounds acting as FLT3 (FLK2/STK1) and interleukin-1 receptor-associated kinase 4 (IRAK-4) inhibitors reported to be ...
Recent developments in the field include an evolving treatment landscape and the development of evidence-based guidelines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback